Psychological problems Study Guide

The study by Daniel, Weinberger, Jones and colleagues (1991) investigated the relationship between cerebral blood flow and specific neuropsychological deficits in patients with schizophrenia. The researchers aimed to understand whether particular cognitive impairments observed in schizophrenia could be linked to abnormalities in brain activity, specifically in the prefrontal cortex, which is known to be involved in executive functions like planning and working memory. They hypothesised that patients with schizophrenia would show reduced blood flow (hypofrontality) in the prefrontal cortex during tasks requiring cognitive effort, compared to healthy control participants.

The methodology involved using Positron Emission Tomography (PET) scans to measure regional cerebral blood flow (rCBF) in participants while they performed cognitive tasks. Participants included individuals diagnosed with chronic schizophrenia and a healthy control group. They completed tasks designed to engage the prefrontal cortex, such as a Wisconsin Card Sorting Test (WCST), which assesses executive function, and a simpler control task. The key finding was that schizophrenic patients, particularly those with more pronounced negative symptoms, exhibited significantly lower blood flow in the prefrontal cortex during the WCST compared to the control group. This hypofrontality was associated with poorer performance on the task. The study provided significant evidence supporting the 'hypofrontality hypothesis' in schizophrenia, suggesting that impaired prefrontal cortical function underlies some of the cognitive deficits seen in the disorder. It highlighted the biological basis of cognitive symptoms in schizophrenia and contributed to a growing understanding of the neurobiology of the condition. Evaluating this study, its strengths include the use of objective brain imaging techniques (PET scans) and a relatively well-controlled experimental design comparing patients to a control group. However, limitations include the correlational nature of the findings (it shows association, not necessarily causation) and the sample size, which limits generalisability. Also, specific task demands might not fully replicate real-world cognitive challenges. The study led to further research into the neurobiological underpinnings of schizophrenia and the development of treatments targeting cognitive symptoms.

Drug therapies, psychotherapy, and neuropsychology represent different approaches to understanding and treating psychological conditions. Drug therapies, often referred to as pharmacotherapy, involve the use of medications to influence brain chemistry and alleviate symptoms of mental health disorders. For instance, antidepressants aim to increase the availability of certain neurotransmitters like serotonin in the brain, which are often linked to mood regulation. Similarly, anxiolytics are prescribed to reduce anxiety by enhancing the effects of GABA, a neurotransmitter that inhibits brain activity. While effective for symptom management, drug therapies may have side effects and often do not address underlying psychological causes.

Psychotherapy, on the other hand, involves a range of talking treatments designed to help individuals understand and resolve their psychological issues through verbal communication and behavioural strategies. Cognitive Behavioural Therapy (CBT), for example, focuses on identifying and changing unhelpful thought patterns and behaviours. Psychodynamic therapy explores how unconscious processes and past experiences influence current behaviour. Unlike drug therapies, psychotherapy aims for long-term change by developing coping mechanisms and insight, often without the need for medication.

Neuropsychology is a field that studies the relationship between the brain, nervous system, and behaviour/cognition. It investigates how brain injuries, diseases, or developmental issues affect psychological functions such as memory, attention, language, and problem-solving. Neuropsychological assessments, often involving a battery of tests, help diagnose specific brain-based conditions and guide rehabilitation strategies. This field informs both drug therapies and psychotherapy by providing a deeper understanding of the biological underpinnings of mental processes and disorders, helping to tailor treatments more effectively.